Open AccessAndrogen receptor axis‑targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
Author(s) -
Akinori Wada,
Mitsuhiro Narita,
Masayuki Nagasawa,
Takuto Kusaba,
Shigehisa Kubota,
Tetsuya Yoshida,
Kazuyoshi Johnin,
Akihiro Kawauchi,
Susumu Kageyama
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13453
Subject(s) - prostate cancer , medicine , hormonal therapy , oncology , hormone therapy , prostate , cancer , castration , androgen deprivation therapy , hormone , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom